Valuation: Stereotaxis, Inc.

Market Cap 85.17M 77.02M 71.1M 64.35M 121M 8.01B 125M 853M 339M 4.28B 320M 313M 13.62B P/E 2026 *
-3.78x
P/E 2027 * -5.15x
Enterprise Value 85.17M 77.02M 71.1M 64.35M 121M 8.01B 125M 853M 339M 4.28B 320M 313M 13.62B EV / Sales 2026 *
2.67x
EV / Sales 2027 * 1.97x
Free-Float
84.26%
Yield 2026 *
-
Yield 2027 * -
1 day-5.56%
1 week-19.05%
Current month-1.46%
1 month-25.44%
3 months-39.29%
6 months-55.73%
Current year-63.04%
1 week 0.8
Extreme 0.8
1.22
1 month 0.8
Extreme 0.8
1.22
Current year 0.8
Extreme 0.8
2.86
1 year 0.8
Extreme 0.8
2.86
3 years 0.8
Extreme 0.8
3.59
5 years 0.8
Extreme 0.8
7.22
10 years 0.47
Extreme 0.47
10.3
Manager TitleAgeSince
Chief Executive Officer - 02/02/2017
Director of Finance/CFO 57 30/09/2019
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 31/01/2005
Chairman - 02/02/2017
Director/Board Member 71 28/09/2016
Date Insider Type Main position Quantity % Market Cap. Importance
01/07/26 Free

Director

43,103 0.0441%
01/07/26 Free

Director

43,103 0.0441%
01/07/26
DAFNA Capital Management LLC
OtherCompany 0 0.0000% -
Change 5-day change 1-year change 3-year change Capi.($)
-5.56%-19.05%-65.02%-42.18% 90.18M
-2.55%+3.32%+18.95%+55.98% 266B
-1.34%+2.57%+5.82%+17.85% 166B
-2.14%-6.11%-23.16%+58.52% 156B
-2.06%-0.99%-57.55%-14.27% 65.41B
-0.01%+4.94%+23.63%+64.77% 60.84B
+0.64%-2.67%-2.28%-8.00% 53.75B
-2.23%+0.72%+14.18%+59.50% 49.89B
-0.77%-2.48%+1.84%+83.20% 49.34B
-1.85%+2.01%+19.32%+80.60% 46.28B
Average -1.58%-0.65%-6.43%+35.60% 91B
Weighted average by Cap. -1.57%-0.26%+1.79%+44.19%

Financials

2026 *2027 *
Net sales 31.9M 28.85M 26.63M 24.1M 45.48M 3B 46.85M 320M 127M 1.6B 120M 117M 5.1B 43.2M 39.07M 36.06M 32.64M 61.59M 4.06B 63.44M 433M 172M 2.17B 162M 159M 6.91B
Net income -22.85M -20.66M -19.07M -17.26M -32.58M -2.15B -33.56M -229M -90.98M -1.15B -85.76M -83.93M -3.66B -17.15M -15.51M -14.32M -12.96M -24.45M -1.61B -25.18M -172M -68.28M -862M -64.37M -62.99M -2.74B
Net Debt - -
Projected Income Statement - Annual - Stereotaxis, Inc.
Logo Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
131
Date Price Change Volume
12/11/26 US$0.8500 -5.56% 1,514,999
11/11/26 US$0.9000 -12.62% 3,162,032
10/11/26 US$1.030 -9.65% 817,949
09/11/26 US$1.140 +4.59% 899,583
06/11/26 US$1.090 +3.81% 967,075
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Stereotaxis, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.8500USD
Average target price
2.667USD
Spread / Average Target
+213.73%
  1. Stock Market
  2. Stocks
  3. STXS Stock